Assess the Effect of Cangrelor at the Therapeutic Dose and a Supratherapeutic Dose Level on the QT/QTc Interval in Healthy Volunteers
Clinical trial NCT00699504 · COMPLETED
Trial details
- NCT number
- NCT00699504
- Sponsor
- The Medicines Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2008-11-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.